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1. Introduction 
Cardiovascular diseases (CVD) are a major health problem in the industrialized countries, 
representing the main cause of death in the world. It is estimated that 17 million people 
globally die of CVD every year and these diseases are responsible for more than half of all 
deaths in Europe [1]. Therefore, primary prevention is becoming an increasing part of public 
health strategies aimed at reducing societal burden due to CVD-related morbidity and 
mortality worldwide. There are several behavioural factors such as tobacco use, ethanol 
consumption, unhealthy diet and physical inactivity that can lead to hypertension, 
hyperlipidemia, diabetes, overweight and obesity, and thereby contribute to CVD 
development. The World Health Organisation emphasises the importance of improved 
nutrition as means of controlling the expected rise in global CVD incidence over the next 
decades. 
Angiotensin I-converting enzyme (ACE: EC 3.4.15.1) is a peptidyldipeptide hydrolase that 
plays an important physiological role in both the regulation of blood pressure and 
cardiovascular function [2] through two different reactions. First, ACE catalyzes the 
hydrolysis of angiotensin I, an inactive decapeptide, to angiotensin II, a powerful 
vasoconstrictor and salt-retaining octapeptide. Thus, ACE-inhibition has a hypotensive 
effect. Secondly, ACE catalyzes the inactivation of the vasodilator bradykinin that regulates 
different biological processes including vascular endothelial nitric oxide (NO) release [3]. 
Oxidative stress has a well documented role in CVD development. Oxidative stress is 
defined as the situation characterized by increased generation of free radicals (reactive 
oxygen species, ROS), resulting in increased oxidative damage of biological structures. 
Within the cell, physiologic levels of some ROS are involved as key intermediates in 
signalling pathways to maintain basal cellular functions. In contrast, when ROS are 
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generated in the absence of a physiological stimulus, small-molecule antioxidants are 
depleted, or antioxidant enzymatic systems are overwhelmed. This leads to a net increase in 
biologically active ROS and oxidant stress ensues. In blood vessels, oxidant stress has 
deleterious consequences for basal vascular function. Then, the cellular mechanisms that 
result in vascular redox imbalance leading to an increase in oxidant stress are implicated in 
the pathogenesis of vascular disease [4]. 
The search for dietary compounds that prevent the development of CVD is deemed crucial 
to tackle this major health problem worldwide, and recent observational studies and clinical 
trials have suggested that increased protein consumption, particularly from plant sources, 
might reduce blood pressure and prevent CVD. Recently, interest has been emerging to 
identify and characterize bioactive peptides from plant and animal sources. Bioactive 
peptides are considered specific protein fragments that are inactive within the sequence of 
the parent protein. After they are released they may exert various physiological functions. 
The type of bioactive peptides generated from a particular protein is dependent on two 
factors: (a) the primary sequence of the source protein and (b) the specificity of the 
enzyme(s) used to generate such peptides. The hydrolysis of plant proteins has led to the 
production of a variety of biologically active peptides, such as opioid, antihypertensive, 
antioxidative, immunomodulatory or antimicrobial peptides [5, 6]. Bioactivity of peptides 
depend on the structure, however, the structure activity relationship is not yet fully 
understood for all biological activities described. This present paper focuses on the peptides 
beneficial to CVD derived from plant proteins.  
2. Biological activities of plant proteins  
Potato tuber proteins are classified into three major groups: patatins, protease inhibitors, 
and other proteins. Patatin is the major storage protein and an allergen for some people. The 
second major potato tuber storage protein is a diverse group of low molecular weight 
protease inhibitors [7]. The majority of the patatin and proteinase inhibitor isoforms possess 
enzymatic and inhibitory activities, respectively, which might be of physiological relevance. 
Activities are associated with the defense mechanisms of potato against pathogens and they 
inhibit a variety of proteases and some other enzymes, for example invertase [8]. Low 
molecular weight antimicrobial potato peptides from potato tubers have recently been 
reported to exhibit antibiotic/antifungal activity also against human pathogenic fungal and 
microbial strains [9]. The broad phospholipase activity of patatin has been characterized and 
documented rather extensively [10, 11]. The results indicate that the patatin-related enzymes 
are, in addition to fat metabolism, involved in the stress responses and signal transduction 
in the potato tubers. Patatin has also been shown to possess antioxidant or antiradical 
activity. Liu and colleagues [12] found that purified patatin exert antioxidant or antiradical 
activity in various in vitro tests, such as radical, scavenging activity assay and protection 
against hydroxyl radical-induced calf thymus DNA damage. Potato protein hydrolysates 
showed antioxidant activity [13] and enhanced oxidative stability of soybean oil emulsions 
[14]. Two peptides derived from metallocarboxypeptidase inhibitor and lipoxygenase 1 
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were identified. Potatoes may have a role in controlling appetite and therefore weight gain, 
by contributing to satiety. Gastrointestinal hormones such as cholecystokinin (CCK) are key 
factors in the regulation of food intake and maintaining energy homeostasis. Hill and 
colleagues [15] reported reduced energy intake and increased CCK release, when protease 
inhibitors extracted from potatoes were tested in 11 lean subjects.  
The protein content of defatted rapeseed meal is high, approximately 32%, making it a 
potential food ingredient. Rapeseed protein has recently been demonstrated to be of high 
nutritional value in human subjects and substituting Cys-rich rapeseed protein, for milk 
protein prevented the early onset of insulin resistance, similar to those achieved by 
manipulating dietary fat and carbohydrates in a rat model [16, 17]. Flaxseed and its defatted 
meal contain high amounts of proteins, which are comparable in amino acid composition to 
food proteins like soy, with a preponderance of basic and branch-chain amino acids. The 
high Cys and Met content can boost the body’s antioxidant levels, potentially stabilising 
DNA during cell division and reducing risk of certain forms of colon cancer [18]. Yet, there 
are only few studies examining rapeseed and flaxseed meals as source of bioactive peptides 
to enhance the value of these rapeseed and flaxseed industry by-products.  
Legumes could represent valuable tools to prevent CVD, in addition to constitute an 
important source of dietary proteins (18-40 %), dietary fibre, minerals and vitamins. 
Epidemiological studies have provided consistent evidence of the inverse relationship 
between legume consumption and the incidence of CVD. The majority of studies that have 
evaluated the hypocholesterolemic effects of legume consumption examined soybeans [19]. 
In addition, the meta-analysis showed that diet rich in legumes, such as a variety of beans, 
peas, and some seeds other than soy decreases total and low-density lipoprotein (LDL) 
cholesterol [20]. Different legumes have been identified as sources of ACE-inhibitory and 
antioxidative peptides, mainly soybean [21-24], chickpea and pea [25-28]. 
Cereal grains contain relatively little protein compared to legume seeds, with an average of 
about 10–12% of dry weight. Storage proteins account for about 50% of the total protein in 
mature cereal grains and have important impacts on their nutritional quality for humans 
and livestock and on their functional properties in food processing. Proteins can be 
separated into albumin, globulin, prolamin (hordein) and gluten fractions as described by 
[29]. The prolamins are characterized by their high content of Pro and Glu and low content 
of Lys and Trp. Alcohol-soluble endosperm proteins (prolamins) from some cereals (e.g. 
wheat, barley, and rye) give origin upon proteolytic digestion to biologically active 
antinutritional peptides able to adversely affect in vivo the intestinal mucosa of coeliac 
patients, whereas prolamins from other cereals (e.g. maize and rice) do not [30]. A large deal 
of cereal proteins originates from by-products following production of starch, malting or 
brewing industry. For example, -zein protein, derived from corn starch production, is rich 
in Pro and hydrolysis by thermolysin liberates ACE-inhibitors [31]. Wheat proteins are also 
source of opioid peptides [32] and tryptic hydrolysate of rice proteins yields the 
immunomodulatory peptide, oryzatensin [33]. 
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2.1. Production of peptides 
ACE-inhibitory peptides have been produced by enzymatic hydrolysis and microbial 
fermentation of food proteins. In addition, solvent extraction has been used to isolate ACE-
inhibitory activity from plant materials, such as mushrooms, broccoli and buckwheat [6]. 
The ACE-inhibitory potency is expressed as the IC50 value (inhibitor concentration leading 
to 50% inhibition), being used to estimate the effectiveness of different hydrolysates and 
peptides. The most common way to produce bioactive peptides is through enzymatic 
hydrolysis of whole protein molecules. The specificity of enzyme and process conditions 
influence the peptide composition of hydrolysates and thus their activities.  
Generally, enzymatic hydrolysis is widely applied to upgrade functional features (such as 
emulsifying properties of hydrolysed protein) and nutritional properties of proteins [34-36]. 
It has been reported that additional advantage of hydrolysis can be the development of 
hydrophobicity since proteolysis unfolds the protein chains. The cleavage of peptide bonds 
enhances levels of free amino and carboxyl groups resulting in enhanced solubility. 
Therefore, hydrolysis can increase or decrease the hydrophobicity, which mostly depends 
on the nature of the precursor protein and molecular weight of the generated peptides [34]. 
Moreover, hydrolysis leads to production of small bioactive peptides [35] and bitterness of 
peptides of below 1000 Da is much less than fractions with a higher molecular mass [36]. 
However, it has been reported that extensive hydrolysis could adversely affect functional 
properties of peptides [37]. Some factors to consider in producing bioactive peptides include 
hydrolysis time, degree of hydrolysis of the proteins, enzyme–substrate ratio, and pre-
treatment of the protein prior to hydrolysis. For example, thermal treatment of proteins can 
enhance enzymatic hydrolysis [38] possibly by increasing enzyme–protein interactions due 
to thermal-induced unfolding of the proteins.  
According to the literature, enzymatic hydrolysis has been the main process for producing 
ACE-inhibitory and antioxidative peptides from food proteins. Use of exogenous enzymes is 
preferred in most cases over the autolytic process (i.e., use of endogenous enzymes present 
in the food source itself), due to the shorter time required to obtain similar degree of 
hydrolysis as well as better control of the hydrolysis to obtain more consistent molecular 
weight profiles and peptide composition [39-45]. Industrial food-grade proteinases such as 
Alcalase, Flavourzyme, and Protamex derived from microorganisms, as well as enzymes 
from plant (e.g. Papain) and animal sources (e.g., pepsin and trypsin), have been widely 
used in producing ACE-inhibitory and antioxidative peptides. The serine type endo-
protease Alcalase, has produced the highest ACE-inhibitory activities in vitro in case of 
several plant proteins (Table 1).  
Alcalase digests of rapeseed, canola, flaxseed, sunflower seed protein, legumes as well as 
and mung and chick beans showed high potency for ACE inhibition [41, 43-48]. Moreover, 
Alcalase digestion increased the ACE inhibition of the protein-rich by-product fraction from 
potato starch industry, potato tuber liquid fraction [13]. The IC50 -values were ranged 
between 0.020 and 0.64 mg protein/ml, which are similar to those  reported for milk whey 
and casein hydrolysates [5, 41, 45-47,49]. Mäkinen and colleagues [50] reported that  
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Source 
protein 
Enzyme or 
other process 
conditions 
ACE
inhibition  
Identified peptides
 
In vivo response Ref 
  IC50
(mg/ml) 
Sequences IC50 value 
(µM) 
Dose 
administratio
n  model 
Response (Δ 
SBP  
mmHg) 
 
Sweetpotato 
tuber 
protein 
isolate 
Thermoase PC 
10F, Protease S 
&  Proleather 
FG-F  
0.018 ITP 
IIP 
GQY 
STYQT 
9.5  
80.8  
52.3  
300.4 
500 mg/kg 
hydrolysate, 
oral, SHR 
 
-30  after 8 h [121]  
Sweetpotato 
tuber 
defensin 
 Trypsin  
 
 
0.190 GFR 
FK 
IMVAEAR 
GPCSR 
CFCTKPC 
MCESASSK
94.25 
265.43 
84.12  
61.67  
1.31  
75.93 
  
 
 
 
[118] 
Sweet 
potato tuber 
Thioredoxin 
h 
Trypsin  
 
 
0.152 EVPK 
VVGAK 
FTDVDFIK
MMEPMVK
1.73  
1.14  
0.42  
1.03  
  [119] 
Sweetpotato 
tuber 
Trypsin 
inhibitor 
 
Pepsin 
 
0.188 HDHM 
LR 
SNIP 
VRL 
TYCQ 
GTEKC 
RF 
VKAGE 
AH 
KIEL 
276.2 
746.4 
228.3 
208.6 
2.3  
275.8  
392.2 
141.56 
523.5  
849.7  
  [120] 
Yam tuber Powdered yam 
product, 
alcohol-
insoluble-solids 
Water extract 
(15% protein) 
Heat treated 
(90°C) water 
extract 
Dioscorin, 
lyophilized yam 
powder  
Storage protein 
ion-exhange 
chromato-
graphy 
Pepsin 
hydrolysate 
ND 
 
  
 
 
60 mg/kg 
oral, SHR 
 
154  mg/kg 
oral, SHR 
154 mg/kg 
oral, SHR 
 
140 mg daily 
oral,  human 
 
40 mg/kg 
 oral, SHR 
 
40 mg/kg 
oral,  SHR  
-32.4 after 
6 h 
 
-30.3 after 
4 h 
-23.87 after 
4 h 
 
-6.52 after  
2 weeks 
 
-27.7 after 9 
days  
 
-32.8 after  8 
hours 
 
[123] 
 
  
 
 
[86] 
[175] 
 
 
[122] 
 
 
[122] 
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Source 
protein 
Enzyme or 
other process 
conditions 
ACE
inhibition  
Identified peptides
 
In vivo response Ref 
  IC50
(mg/ml) 
Sequences IC50 value 
(µM) 
Dose 
administratio
n  model 
Response (Δ 
SBP  
mmHg) 
 
Potato tuber Autolysed 
protein extract 
Alcalase digest 
of potato tuber 
liguid fraction 
0.36 
 
0.018 
    [50] 
 
[13] 
  
Apios 
Americana 
Medikus 
tuber 
Water extract 
(rich in proline)
127   200 mg/kg 
oral, SHR  
-25 after 0.5 
and 1 h 
 
[124] 
Rapeseed 
protein 
Pepsin  
Subtilisin 
  
 
 
 
0.16 
0.16 
 
 
 
 
 
VWIS 
VW 
IY 
RIY 
 
 
30  
1.6  
3.7 
28  
500 mg/kg 
hydrolysate,  
12.5 mg/kg 
7.5 mg/kg 
7.5 mg/kg 
7.5 mg/kg 
oral, SHR  
-6.8 after  4h  
-15.5 after 4h 
-12.5 after 2 h 
-10.8 after 2 h 
-9.8 after 2 h 
-11.3 after 4h 
[125] 
Rapeseed 
protein 
Alcalase  
Peptide fraction 
from affinity 
purification 
Alcalase 
0.038 
0.25x10-3 
 
 
 
0.020 
 
 
   [45] 
 
 
 
 
[47] 
Canola 
meal,  
defatted 
Heat treatment 
and  Alcalase 
0.027 VSV 
FL 
0.15 
1.33 
  [46]  
Flaxseed 
protein 
Trypsin & 
Pronase cationic 
peptide fraction
0.4 QGR 
RW 
SVR 
GQMRQPI
QQQG 
ASVRT 
DYLRSC 
ARDLPGQ
RDLPG 
RGLERA 
TCRGLERA
 200 mg/kg 
hydrolysate, 
oral, SHR 
-17.9 after 
2 h 
[44] 
Flaxseed 
protein 
Gastrointestinal
digest in vitro, 
<1kDa  
permeate 
fraction 
 
0.040 
 
WNI/LNA 
NI/LDTDI/L 
   [127]  
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Source 
protein 
Enzyme or 
other process 
conditions 
ACE
inhibition  
Identified peptides
 
In vivo response Ref 
  IC50
(mg/ml) 
Sequences IC50 value 
(µM) 
Dose 
administratio
n  model 
Response (Δ 
SBP  
mmHg) 
 
Sunflower 
protein 
Alcalase 
Peptide fraction 
from affinity 
purification 
0.062 
1.18x10-3 
    [61]  
Pea protein  Gastrointestinal 
digest in vitro  
0.070 
 
  50 mg/kg 
intravenous, 
SHR 
-44, transient 
and sharp 
reduction 
[144] 
Pea protein 
isolate  
Thermolysin, 
3kDa MWCO 
permeate 
ND    200 mg/kg 
oral, SHR 
25-30 g/day 
oral, 
Han:SPDR-cy 
rat 
3g/day 
 oral, Human, 
consumption 
-19 after 4h 
 
-30 at weeks 
7 and 8 
 
 
-6 after  3 
weeks 
[143]  
Chick pea 
protein  
Alcalase  Peptide 
fractions 
0.103- 
0.117 
mg/ml 
  [41] 
Chick pea 
legumin  
Alcalase  Peptide 
peaks 
0.011-0.021 
mg/ml 
  [43] 
Common 
beans 
Pinto beans  
Green 
lentils 
Heat treatment 
and  in vitro 
gastro-intestinal 
digestion  
0.78-0.83  
0.15-0.69  
0.008-0.89   
    [131] 
Red  and  
green lentil 
protein  
In vitro gastro-
intestinal 
digestion 
0.053- 0.190     [64] 
Mung bean 
protein  
Alcalase, 6kDa 
MWCO 
permeate 
0.64  KDYRL 
VTPALR 
KLPAGTLF
26.5  
82.4  
13.4  
600 mg/kg 
oral, SHR 
-30.8 after 
6 h 
[48] 
Mung bean 
sprout 
 
Raw sprout 
extract 
Dried sprout 
extract 
Pepsin, trypsin 
and 
chymotrypsin 
 
 
  600 mg/kg 
intragastric, 
SHR 
-41 after 6 h 
-24 after 3 h 
-29 after 3 h 
[142] 
Soy protein Alcalase 0.065  DLP 
DG 
4.8 
12.3 
  [39] 
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Source 
protein 
Enzyme or 
other process 
conditions 
ACE
inhibition  
Identified peptides
 
In vivo response Ref 
  IC50
(mg/ml) 
Sequences IC50 value 
(µM) 
Dose 
administratio
n  model 
Response (Δ 
SBP  
mmHg) 
 
Soybean Fermentation 0.45 AW 
GW 
AY 
SY 
GY 
AF 
VP 
AI 
VG 
µg/ml 
0.03 
0.05 
0.07 
0.10 
0.19 
0.48 
0.69 
1.1 
Diet contained 
10% v/w of 
fermented soy 
product 
oral, SHR 
-20 after 11 
week 
[184] 
Rye Sourdough 
Lactobacillus 
reuteri TMW 
1.106 and added 
protease 
 VPP 
IPP 
LQP 
LLP 
9 
5 
2 
57 
  [149] 
Rice Alcalase 0.14 TQVY 18.2 600 mg/kg 
hydrolysate 
30 mg 
peptide/kg 
SHR, oral 
-25.6 after 
6 h 
-40 after 6 h 
[153] 
Maize, α-
zein 
Thermolysin  LRP 
LSP 
LQP 
0.29 
1.7 
2.0 
Peptide (LRP)
30 mg/kg  
SHR, 
intravenous 
-15  2 min 
after 
injection 
[31] 
Wheat bran Autolysis 0.08 LQP 
IQP 
LRP 
VY 
IY 
TF 
 
peptide-
fraction 
0.14 
mg/ml 
 10 mg/ml 
oral, SHR 
-45 after 2 h [185] 
[186] 
Table 1. ACE-inhibitory activities in vitro and antihypertensive effect in vivo of plant protein–derived 
hydrolysates and peptides   
autolysis of protein isolates from the potato tuber tissue enhances ACE-inhibition which 
may be due to the native proteolytic activity of potato tuber proteins.  
Peña-Ramos and Xiong [51] used different enzymes to produce hydrolysates from native 
and heated soy protein isolates. They reported that using different enzymes resulted in the 
formation of a mixture of peptides with different degrees of hydrolysis and accordingly 
different ranges of antioxidant activity. It has been found that antioxidant activity of 
Alcalase derived hydrolysates is higher than that of other hydrolysates [52-54]. It is also 
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reported that peptides produced by Alcalase have diverse biological activities, including 
antioxidant activity [55]. In comparison to other proteases, it provided higher yields of 
antioxidative peptides and develops shorter peptides. Udenigwe and colleagues [55] 
observed that release of radical scavenging peptides depends on the specificity of protease 
used in hydrolysis. In another study, flaxseed protein was treated with thermolysin 
followed by pronase to produce antioxidant peptides [42]. Moreover, pepsin, pancreatin, 
neutrase and esperase have been used to produce antioxidative hydrolysates and peptides 
[13, 42, 51, 56, 57].  
Simulated gastrointestinal enzymatic process has also been used to mimic normal human 
digestion of proteins to evaluate the possibility of releasing potent bioactive peptides after 
normal consumption of food proteins. The combination of pepsin-trypsin-chymotrypsin or 
pepsin-pancreatin has been used to simulate the gastrointestinal degradation of proteins in 
humans [58]. Pepsin treatment alone cannot effectively elicit ACE-inhibitory peptides from 
buckwheat protein, while this enzyme followed by chymotrypsin and trypsin lead to a 
significant increase in ACE-inhibitory activity [59]. In some studies, plant protein 
hydrolysates generated during pepsin digestion have potent ACE-inhibitory peptides. 
Lower ACE-inhibitory activity was found after subsequent digestion with pancreatin, 
suggesting that the active components were hydrolyzed [60, 61]. For the pea proteins, high 
ACE-inhibitory activity is reached at the early stage of pepsin hydrolysis and the level is 
maintained during the small intestine phase using trypsin-chymotrypsin treatment [62]. 
While digestion of red lentils with trypsin showed moderate ACE inhibition (IC50 value of 
0.44 mg/ml), addition of pepsin and chymotrypsin clearly improved it (IC50 of 0.09 mg/ml) 
[63, 64].  
Careful choice of suitable enzymes and digestion conditions such as optimal temperature, 
degree of hydrolysis and enzyme-substrate ratio, as well as the control of hydrolysis time, 
are crucial for obtaining protein hydrolysates with desirable functional and bioactive 
properties. Hydrolysis can be performed by conventional batch hydrolysis or by continuous 
hydrolysis using ultrafiltration membranes. The traditional batch method has several 
disadvantages, such as the relatively high cost of the enzymes and their inefficiency 
compared to a continuous process, as noted in numerous studies [65, 66]. The hydrolysis 
process is feasible to scale-up production of peptides from laboratory scale to pilot and 
industrial plant scales with conserved peptide profiles and bioactivity of the resulting 
products [67]. The crude protein hydrolysate may be further processed, for example by 
passage through ultrafiltration membranes, in order to obtain a more uniform product with 
the desired range of molecular mass [68]. Alcalase hydrolysate from soy isolate was 
ultrafiltrated with 1-30 kDa membranes and ACE-inhibitory activities were analysed. The 
IC50-values for 1 kDa and 10 kDa permeates were almost the same, 0.080 and 0.078 mg/ml, 
respectively, but recovery yield of 10 kDa permeate was much higher than that of 1 kDa 
permeate [69]. Ultrafiltration membrane reactors have been shown to improve the efficiency 
of enzyme-catalysed bioconversion, to increase product yields, and to be easily scaled up. 
Furthermore, ultrafiltration membrane reactors yield a consistently uniform product with 
desired molecular mass characteristics [65, 68]. Low molecular mass cut-off membranes are 
useful for concentrating bioactive peptides from the higher molecular mass components 
 Bioactive Food Peptides in Health and Disease 154 
remaining, including undigested polypeptide chains and enzymes. Other techniques such as 
nanofiltration, ion-exchange membranes, or column chromatographic methods can be used 
in further concentration and purification of the peptides [70]. 
A number of studies have shown that antihypertensive peptides are liberated during 
fermentation of milk. Fermented milk products prepared using different strains of lactic acid 
bacteria have been found to exert antihypertensive and antioxidative activities [71, 72]. 
Moreover, several antioxidative and ACE-inhibitory peptide sequences have been identified 
from fermented milk [73]. Only few experimental investigations to produce these 
compounds by fermentation of plant proteins have been reported. Fermentation of rapeseed 
and flaxseed proteins with Lactobacillus helveticus and Bacillus subtilis yields to products 
containing compounds with ACE-inhibitory and inhibition of lipid peroxidation capacities 
[74]. Fermented soybean products such as natto, tempeh, and douche also contain 
antioxidative and ACE-inhibitory peptides due to the action of fungal proteases. The results 
have indicated that the processing techniques have an impact on the ACE-inhibitory 
activities of soy products. Different fermented soybean foods showed IC50 values of 0.51 
mg/ml for tempeh, 1.77 mg/ml for tofuyo, 3.44 and 0.71-17.80 mg/ml for soy sauce, 5.35 and 
1.27 mg/ml for miso paste, and 0.16, 0.19 and 0.27 mg/ml for natto [24,75, 76]. Commercial 
Chinese style soy paste exhibited ACE-inhibitory activities with the lowest and the highest 
IC50 values of 0.012 and 3.241 mg/ml, respectively [77]. Tsai and colleagues [78] fermented 
soy milk with lactic acid bacteria (Lb. casei, Lb., acidophilus, Lb. bulcaricus, Streptococcus 
thermophilus and Bifidobacterium longum) and IC50-value was 2.89 mg/ml after 30 h 
fermentation. When a protease (Prozyme 6) was added after 5 h fermentation, much lower 
IC50-value (0.66 mg/ml) was obtained. Natto has shown to have radical scavenging activity 
and inhibitory effect on the oxidation of rat plasma LDL in vitro [79]. The aqueous extracts of 
Douchi showed radical scavenging activities and chelating ability of ferrous ions. The 
radical scavenging activities were higher than that of Trolox, an analogue of vitamin E used 
as a standard [80]. 
2.2. Structure-activity relationship 
ACE-inhibitory peptides are generally short sequences often carrying polar amino acid 
residues like Pro. This is in agreement with the results of Natesh and co-workers [81] who 
showed that the active site of ACE cannot accommodate large peptide molecules. The C-
terminal tripeptide strongly influences the binding of substrate or a competitive inhibitor to 
ACE. Many ACE-inhibitory peptides identified from different food sources, structure–
activity studies indicated that C-terminal tripeptide residues play a predominant role in 
competitive binding to the active site of ACE. It has been reported that this enzyme prefers 
substrates or inhibitors containing hydrophobic (aromatic or branched side chains) amino 
acid residues at each of the three C-terminal positions. The most effective ACE-inhibitory 
peptides identified contain Tyr, Phe, Trp, and/or Pro at the C-terminal. In addition, 
structure–activity data suggests that the positive charge of Lys (εamino group) and Arg 
(guanidine group) as the C-terminal residue may contribute to the inhibitory potency [82-
84]. Quantitative structure–activity relationship (QSAR) modelling was used to develop 
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statistical computer models potentially capable of identifying ACE-inhibitory peptides 
based on structure–activity data [85]. A relationship was found between hydrophobicity and 
positively charged amino acid in C-terminal position, size of amino acid next to C-terminal 
position and ACE inhibition of peptides up to six amino acids in length. Moreover, no 
relationship between N-terminal structure and inhibition activity was found.  
The exact mechanism underlying the antioxidant activity of peptides has not fully been 
understood, as various studies have displayed that they are inhibitors of lipid peroxidation, 
scavengers of free radicals and chelators of transition metal ions [86, 87]. In addition, it has 
been reported that antioxidative peptides keep cells safe from damage by ROS through the 
induction of genes [88]. Antioxidative properties of the peptides are more related to their 
composition, structure, and hydrophobicity. Tyr, Trp, Met, Lys, Cys, and His are examples 
of amino acids that cause antioxidant activity. Amino acids with aromatic residues can 
donate protons to electron deficient radicals. This property improves the radical scavenging 
properties of the amino acid residues [89, 90]. It is proposed that the antioxidative activity of 
His containing peptides is in relation with the hydrogen donating, lipid peroxyl radical 
trapping and/or the metal ion chelating ability of the imidazole group [87, 91]. On the other 
hand, SH group in Cys has an independently crucial antioxidant action due to its direct 
interaction with radicals [92]. In addition to the amino acid composition, their correct 
position in peptide sequence plays an important role in antioxidative properties of peptides. 
Chen and colleagues [93] designed 28 synthetic peptides following the structure of an 
antioxidative peptide (Leu-Leu-Pro-His-His) from digestion of soybean protein conglycinin. 
According to the results, Pro-His-His sequence displayed the greatest antioxidative activity 
among all tested peptides. The antioxidant activity of a peptide was more dependent on 
His-His segment in the Leu-Leu-Pro-His-His-domain and its activity was decreased by 
removing a His residue from the C-terminus. Moreover, substitution of L-His by D-His in a 
peptide leads reduction of activity [93]. They concluded that the correct position of 
imidazole group is the key factor influencing the antioxidant activity. Saito and co-workers 
[94] also studied antioxidative activity of peptides created in two tripeptide libraries. 
According to their results, for the 114 peptides containing either His or Tyr residues, 
tripeptides containing two Tyr residues showed higher activity in the linoleic acid 
peroxidation system than tripeptides containing two His residues. Further, Tyr-His-Tyr 
showed strong synergistic effects with phenolic antioxidants. It has been shown that certain 
amino acids can exert higher antioxidative properties when they are incorporated in 
dipeptides [95] and some peptide bond or its structural conformation can reduce the 
antioxidant activity of the constituent amino acids [96].  
2.3. In vitro and in vivo activity 
The search for in vitro ACE-inhibitors is the most common strategy followed in the selection 
of potential antihypertensive peptides derived from food proteins. In vitro ACE-inhibitory 
activity is generally measured by monitoring the conversion of an appropriate substrate by 
ACE in the presence and absence of inhibitors. There are several methods, and those based 
on spectrophotometric [97-99] and high-performance liquid chromatography (HPLC) assays 
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are most commonly utilized [100-102]. Hippuryl-His-Leu (HHL) is one of the oldest and 
most used methods for determining the ACE activity or inhibition [97, 99-101]. The broadly 
used spectrophotometric method of Cushman and Cheung [97] is based on the hydrolysis of 
HHL by ACE to hippuric acid and His-Leu, and the extent of hippuric acid released is 
measured after its extraction with ethyl acetate. The liberated hippuric acid can also be 
measured by chromatographic assays avoiding the extraction step [102]. The method based 
on the substrate 2-furanacryloyl-phenylalanylglycyl-glycine (FAPGG) was developed by 
Holmquist and colleagues [103] and can be applied in microtiter plates [98]. Substrates such 
as o-aminobenzoylglycyl-p-nitrophenylalanylproline are designed to perform in 
fluorometric assays [104, 105]. 
Specific assays have not yet been developed or standardized to measure the antioxidative 
capacity of peptides or peptide mixtures. Therefore, assays that are commonly used for 
measuring antioxidative capacity of non-peptidic antioxidants have been used in the 
literature to measure the antioxidative capacity of peptides as well. Due to the complexity of 
oxidative processes occurring in food or biological systems as well as the different 
antioxidative mechanisms by which various compounds may act, finding one method that 
can characterize the overall antioxidative potential of food is not an easy task. Nevertheless, 
methods such as the Trolox equivalent antioxidant capacity (TEAC) assay, oxygen radical 
absorbance capacity (ORAC) assay, and the total radical-trapping antioxidant parameter 
(TRAP) assay have been widely reported in the literature for measuring antioxidative 
capacity of food and biological samples [106, 107]. Commonly used assays include 
measuring the inhibition of lipid peroxidation in a linoleic acid model system and  
the capacity to scavenge the 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)/2,2-
Diphenyl-1-picrylhydrazyl (ABTS/DPPH) radicals. 
In vitro cultured cell model systems allow for rapid, inexpensive screening of compounds 
for their bioavailability, metabolism, as well as bioactivity, compared to expensive and time-
consuming animal studies and human clinical trials. Endothelial cells are currently used as 
in vitro model systems for various physiological and pathological processes, especially in 
angiogenesis research. Endothelial dysfunction, an initiator of atherosclerosis, is manifested 
by altered NO and endothelin-1 (ET-1) homeostasis. ET-1 is one of the most potent 
endogenous vasoconstrictors and impaired NO release precedes the development of 
atherosclerosis [108]. NO is produced by the enzyme endothelial NO synthase (eNOS) 
which converts L-Arg in the presence of O2 and NADPH into L-citruline and NO. There are 
several assays available to analyze NO, ET-1, or expression of eNOS after exposure to 
compounds of interest. Use of cell culture models for antioxidant research is particularly 
important since the studies to date have demonstrated that the mechanism of the action of 
antioxidants in human health promotion go beyond the antioxidant activity of scavenging 
free radicals [109]. During experiments, intracellular oxidation of cells can be induced by 
using a peroxy radical generator or by using hydrogen peroxide (H2O2) [110]. The 20,70-
dichlorofluorescein diacetate (DCFH-DA) probe can be used to measure the extent of 
intracellular radical formation with and without added antioxidative compound in order to 
assess the cellular antioxidant activity (CAA) [111].  
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The antihypertensive effects can be assessed by in vivo experiments using spontaneously 
hypertensive rats (SHR) that constitute an accepted animal model to study human essential 
hypertension [88]. A great number of studies have addressed the effects of both short-term 
and long-term administration of potential antihypertensive milk protein-derived peptides 
using this animal model [88, 112]. In vitro measurements of antioxidant capacity of 
compounds in interest cannot be directly related to their capacity in vivo. Biomarkers of lipid 
and protein peroxides as well as DNA damage can be assessed to monitor changes in 
oxidative stress in vivo. Only few studies so far have been done on plant derived peptides in 
animal models or human clinical trials. 
2.4. ACE-inhibitory and antioxidant peptides 
2.4.1. Potato and other root crops 
During the last decade the in vitro capacity of tuber protein -derived peptides to inhibit ACE 
have gained increasing interest (Table 1). Hsu and colleagues [113] reported that yam 
(Dioscorea alata) tuber dioscorin possess high ACE-inhibitory capacity and the digestion with 
pepsin increased the efficacy further. Moderate ACE-inhibition in vitro has been reported for 
purified yam (Dioscorea batatas) tuber mucilage [114] and for an enzymatic digest as well as 
for an autolysate of yam (Dioscorea opposita) tuber extract [115, 116]. However, the potential 
impact of other compounds, such as phenolic compounds and sugars, on the observed ACE 
inhibition should be taken into consideration. It has been shown that naturally occurring 
phenolic compounds, such as flavonoids and proanthocyanidins, have inhibition activity 
towards ACE [117].  
Sweet potato proteins defensin and thioredoxin h2 which were overproduced in Esherichia 
coli showed moderate ACE-inhibitory capacity (IC50 of 0.190 and 0.152 mg/ml, respectively) 
and both proteins showed mixed type inhibitor against ACE using FAPGG as substrate. 
Hydrolysis with trypsin increased the capacity. Several peptides contained in the 
hydrolysate with IC50 values from 1.31 to 265.43 µM were analyzed [118, 119]. Trypsin 
inhibitor from the root storage protein of sweet potato, inhibited ACE in a dose-dependent 
manner (50-200 µg/ml, with 31.9-53.2% inhibition), and the IC50 value was 187.96 µg/ml. 
After digestion with pepsin the ACE-inhibition increased and peptides were designed by 
simulating the pepsin cutting sites of sporamin A. Finally, ten new ACE-inhibitory peptides 
showed IC50-values from 2.3 to 849.7 µM [120]. Sweet potato protein isolate digested with 16 
different proteases showed variability in digestibility from 44.7 to 97.3% and IC50 values 
from 0.16 to 1.08 mg/ml. Based on these results four most potent enzymes (Thermoase PC 
10F, Protease S, Proleather FG-F and Orientase 22BF) were selected and combined effect of 
enzymes were tested. Combination of Thermoase PC 10F, Protease S and Proleather FG-F 
produced potent ACE-inhibition (IC50 of 0.137 mg/ml). Finally, four different peptides 
derived from sweet potato storage protein, sporamin, were identified with IC50 values from 
9.5 to 300.4 µM [121]. The lowest IC50 values were obtained for synthetic tripeptides, Ile-Thr-
Pro (9.5 µM), Gly-Gln-Tyr (52.3 µM) and Ile-Ile-Pro (80.8 µM). 
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The protein-rich by-product fraction from potato (Solanum tuberosum) starch industry, 
potato tuber liquid, has been found to be a valuable source of ACE-inhibitory peptides [13]. 
The ACE-inhibitory activity of potato tuber liquid was moderate and enzymatic digestion 
was needed to enhance the activity to high level. Alcalase digest showed the highest ACE-
inhibitory activity and the digest was chromatographically separated to highly active 
peptide fractions. The potato liquid Alcalase hydrolysate produced the highest radical 
scavenging potency even though no statistically significant differences were found among 
hydrolysates produced by Alcalase, Neutrase and Esperase. Mäkinen and colleagues [47] 
reported that autolysis of protein isolates from the potato tuber tissue enhances ACE 
inhibition which may be due to the native proteolytic activity of potato tuber proteins. The 
results indicated a relevant role of potato tuber storage proteins in the production of ACE-
inhibitory peptides during the autolysis. Enrichment of recombinant potato tuber protein to 
the autolysis enhanced the production of activity significantly, which suggests possibility to 
enhance potato tuber ACE-inhibitory potential by means of biotechnological tools. Anyhow, 
more research is needed to characterize and identify the ACE-inhibitory potato peptides and 
to evaluate the in vivo antihypertensive potential. 
Recently, antihypertensive effects of some tuber plant –derived protein digests have been 
evaluated in vivo using SHR animal model, although no tuber protein –derived peptides in 
pure form have been reported. The proteins tested in the in vivo trials have concerned the 
antihypertensive effects of the main storage proteins of the tubers and peptides derived 
from these proteins. Among the tuber proteins, the in vivo antihypertensive effects of yam 
(Dioscorea alata) tuber proteins are the most studied. Lin and co-workers [122] purified 
storage proteins, dioscorins from yam tubers, that were digested with pepsin and evaluated 
for their  antihypertensive effects in SHR. The maximum effect after single oral 
administration was observed after 4 h with the dioscorin isolate and after 8 h with the peptic 
hydrolysate, while the antihypertensive effect of the peptic digest was more pronounced (-
33.7 mmHg Mean arterial pressure, MAP) and less transient than that of the dioscorin 
isolate (-21.5 mmHg MAP). The long-term antihypertensive effect of the dioscorin isolate 
was tested for 25 days with daily oral administration and the greatest reductions in systolic 
blood pressure (SBP) and diastolic blood pressure (DBP) were observed on the ninth day. 
Liu and co-workers [123] tested the antihypertensive effects of different yam tuber products 
on SHR. The yam tuber alcohol-insoluble solids and water extract before and after heat 
treatment were observed to decrease the blood pressure after single oral administration. The 
most pronounced effect with the lowest dose was found with the alcohol-insoluble-solids 
product, which contained the yam tuber dioscorins. Iwai and Matsue [124] reported 
moderate antihypertensive effects of an edible tuber Apios Americana Medikus in SHR. The 
animals ingested water extract of the tubers that was rich in Pro. The antihypertensive effect 
was suggested to be due to Pro-rich peptides, which were released during digestion. Sweet 
potato protein digest made with combination of three proteases (Thermoase PC10F, 
Protease S and Proleather FG-F) showed a dose dependent decrease in SBP after single oral 
administration in SHR [121].  
 
Antihypertensive Properties of Plant Protein Derived Peptides 159 
2.4.2. Oil seed plants-derived peptides 
According to the published data, enzymatic hydrolysis is required to release 
antihypertensive peptides from oil seed plant proteins. Only few peptide sequences have 
been identified from oil seed plants. Four ACE-inhibitory peptides were isolated from the 
rapeseed subtilisin digest of which Ile-Tyr and Arg-Ile-Tyr can be found in the primary 
structure of napin and Val-Trp and Val-Trp-Ile-Ser exist in the primary structure of 
cruciferin and ribosomal protein, respectively. Among the peptides isolated, Ile-Tyr and 
Val-Trp can be considered true ACE-inhibitors because IC50 values for these peptides before 
and after pre-incubation with ACE were found to be the same. Val-Trp-Ile-Ser is a pro-drug 
type ACE-inhibitor, as pre-incubation with ACE of Val-Trp-Ile-Ser intensified inhibitory 
activity of this peptide [125]. In addition, to these rapeseed peptides, two peptide sequences 
with high ACE-inhibitory capacity were identified from canola meal hydrolysed with 
Alcalase, Val-Ser-Val and Phe-Leu, located in the primary structure of canola napin and 
cruciferin proteins [46]. Low-molecular weight cationic peptide fractions from flaxseed 
protein hydrolysed by Alcalase or thermolysin showed concentration dependent ACE-
inhibition (IC50 0.0275-0.151 mg/ml) [126]. The Alcalase cationic peptide and thermolysin 
hydrolysate showed mixed type inhibition of ACE activity. Several peptides were detected 
in a cationic peptide fraction of a trypsin & Pronase digest of flaxseed, which showed 
moderate ACE inhibition in vitro and antihypertensive effects in SHR [44]. A pentapeptide 
Trp-Asn-Ile-Leu-Asn-Ile-Leu and a hexapeptide Asn-Ile-Leu-Asp-Thr-Asp-Ile-Leu were 
identified from flaxseed protein digested with an in vitro digestion model [127]. Anyhow, 
ACE-inhibitory activity of these flaxseed derived peptides has not been evaluated 
individually and thus, the ACE-inhibitory capacity of these peptides in a pure form is not 
clear [44, 126, 127].  
Despite the high in vitro ACE-inhibitory potency of Alcalase digests of oil seed proteins, 
their antihypertensive effects in vivo have not been evaluated yet. Subtilisin digest of 
rapeseed and tryptic digest of flaxseed have shown antihypertensive properties in SHR. 
Marczak and co-workers [125] studied the Subtilisin and pepsin digests of rapeseed in SHR. 
Subtilisin digest of rapeseed protein showed dose dependent antihypertensive effect after 
oral administration to SHR and its effect was significant even at a single dose of 0.15 g/kg. 
The Subtilisin digest was subjected to hydrolysis with different proteases to simulate 
gastrointestinal digestion in vitro and the ACE-inhibitory activity was changed only slightly 
indicating that ACE-inhibitory peptides present in the Subtilisin digest are relatively 
resistant. The antihypertensive activities of Val-Trp, Val-Trp-Ile-Ser, Ile-Tyr and Arg-Ile-Tyr 
were tested following oral administration to SHR. The maximum hypotensive activity of 
Val-Trp, Val-Trp-Ile-Ser and Ile-Tyr occurred 2 h after administration, whereas Arg-Ile-Tyr 
(rapakinin) had the maximum effect 4 h after administration. All peptides displayed dose-
dependent antihypertensive effect. Hypotensive activity of the peptides was compared after 
oral administration to young (19-20 weeks) and old (28-30 weeks) SHR. Usually the 
hypotensive effect of ACE inhibitors in old SHR is lower than in young SHR. The 
hypotensive effects of Val-Trp, Val-Trp-Ile-Ser and Ile-Tyr were lower in old rats, but in the 
case of rapakinin the effect was similar in old and young rats. The authors suggested that 
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another mechanism besides ACE inhibition may be involved in hypotensive effect of 
rapakinin. Recently, the hypotensive effect of rapakinin was found to be mediated mainly 
by the prostaglandin IP (PGI2-IP) receptor followed by CCK1 receptor-dependent 
vasorelaxation [128]. In addition to hypotensive effects, the napin-derived peptide rapakinin 
has been reported to possess multifunctional properties. Rapakinin dose-dependently 
decreased food intake and gastric emptying after oral administration at a dose of 150 mg/kg 
in mice [129] and recently, Yamada and colleagues [130] reported anti-opioid activity related 
to the hypotensive effects for rapakinin. 
Peptide fraction from the enzymatic digest of flaxseed protein was recently reported to 
possess hypotensive activity in SHR [44]. An Arg-rich peptide fraction was produced from 
flaxseed protein using trypsin and pronase and by subsequent concentration with combined 
electrodialysis and ultrafiltration. The hypotensive effect of the flaxseed derived Arg-rich 
peptide fraction was tested on SHR and the effects were compared to the effects of inherent 
flaxseed protein isolate and amino acid form of Arg. The maximum hypotensive effect of the 
cationic peptide fraction was observed already 2 h after oral administration while the amino 
acid form of Arg showed lower hypotensive activity, -10.3 mmHg. On the other hand, the 
flaxseed protein isolate exhibited a slow-acting hypotensive effect with maximum of -18.4 
mmHg (SBP) at 6 h after the administration. The hypotensive effect of the Arg-rich peptide 
fraction was longer-lasting when compared to the free amino acid form of Arg and the 
authors suggested that this might be related to more efficient absorption of peptides and the 
ability of peptides to translocate directly into the cells, obviating the need for transporters. 
The observed hypotensive activity of flaxseed protein and peptide fraction could be due to 
vasodilatory activity of NO synthesized from the Arg through the L-Arg-NO pathway in the 
vascular endothelium, or ACE- and renin-inhibition observed in vitro by the cationic peptide 
fraction. 
2.4.3. Legume derived peptides 
Several enzymes have been used to produce pulse protein hydrolysates having bioactive 
properties. It has been suggested that hydrolysates of chickpea legume and mung bean 
obtained by Alcalase treatments are good sources of ACE-inhibitory peptides [43, 48]. 
Potential ACE-inhibitory potencies of common dry beans, dry pinto beans and green lentils 
increased during in vitro gastrointestinal digestion have been reported, with IC50 values of 
0.78–0.83, 0.15–0.69 and 0.008–0.89 mg protein/ml, respectively [131]. In addition, 15 min 
heat treatment effectively increased the ACE-inhibitory activity of the stomach digest [43, 
131]. Digestion simulating the physiological conditions of pea proteins sufficed to achieve 
the highest ACE-inhibitory activity with IC50 value of 0.076 mg/ml [132]. Furthermore, it has 
been suggested that red lentil protein hydrolysates have ACE-inhibitory properties. The 
ACE-inhibitory property of the tryptic hydrolysates varied as a function of the protein 
fraction with the total lentil protein hydrolysate having the lowest IC50 (0.440 ± 0.004 mg/ml). 
This indicates that lentil varieties having higher amounts of legumin and albumin proteins 
may have higher ACE-inhibitory properties [63]. Pedroche and co-workers [41] hydrolysed 
chickpea protein isolate with Alcalase to produce a bioactive hydrolysate having ACE-
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inhibitory properties with an IC50 value of 0.190 mg/ml. Four peptide-fractions with average 
molecular weight of 900 Da, representing peptides with six to eight amino acid residues 
were isolated. The IC50 values were 0.103-0.117 mg/ml and two of the peptides showed 
competitive and two showed uncompetitive mechanism [41]. In addition, six ACE-
inhibitory peptides with IC50 values ranging from 0.011 to 0.012 mg/ml have been isolated 
from chickpea hydrolysed by Alcalase. All these peptides contained Met and were rich in 
other hydrophobic amino acids [43]. Two lentil varieties were hydrolysed with different 
enzymes and IC50 values ranged between 0.053 and 0.190 mg/ml. Furthermore, the 
inhibition mechanism investigated using Lineweaver–Burk plots revealed a non-competitive 
inhibition of ACE with inhibitor constants (Ki) between 0.16 and 0.46 mg/ml [40]. Three 
dipeptides, Ile-Arg, Lys-Phe and Glu-Phe were isolated and identified from Alcalase 
hydrolysate of pea protein isolate. The peptides showed strong inhibitions (IC50 values <25 
mM) of ACE and renin [133]. 
Enzymatic hydrolysate of soy protein showed a moderate ACE-inhibitory activity (0.034 
mg/ml) [39] as compared with values  reported ranging from 0.021 to 1.73 mg/ml [5, 6, 49, 
70]. Lo and co-workers [134] applied the dynamic model for the in vitro digestion of isolated 
soy proteins. They concluded that ACE-inhibitory activity was dependent on the digestion 
time and the heat treatment of soy protein. Pepsin hydrolysis of isolated soy protein 
produced peptides with a higher ACE-inhibitory activity due to the increased digestion 
time. Hydrolysis by pancreatin produced soy peptides with higher ACE‑inhibitory activity 
as compared to pepsin hydrolysates, but decresed inhibitory activity appeared after longer 
digestion time. These results suggest that at the longer digestion time pancreatin may have 
hydrolysed the peptides from pepsin digestion that had strong ACE-inhibitory activity, and 
then turned them into peptides with lower ACE-inhibitory activity.  
Pea protein hydrolysates by thermolysin contained low molecular weight (<3 kDa) peptides 
with various antioxidant activities that were dependent on the amounts of hydrophobic and 
aromatic amino acid constituents [135] (Table 2). Peptide fractions with the least cationic 
property had significantly stronger scavenging activity against DPPH and H2O2. Generally, 
the scavenging of O2˙− and H2O2 was negatively related with the cationic property of the 
peptide fractions [136]. Chick pea hydrolysate with antioxidant activities was prepared from 
chickpea protein isolates by Alcalase. This hydrolysate was separated with Sephadex G-25. 
Four fractions were obtained, and fraction IV had the highest antioxidant activities assayed 
by free radical scavenging effects [137]. The active peptide was identified as Asn-Arg-Tyr-
His-Glu. This peptide quenched the free radical sources DPPH, hydroxyl, and superoxide 
free radicals. Furthermore, the inhibition of the peptide on lipid peroxidation was greater 
than that of -tocopherol [57]. 
Different hydrolysis conditions of soy protein isolates have resulted in peptide mixtures 
with different antioxidant properties. Native and heated soy protein isolate hydrolysed with 
different enzymes resulted in different degree of hydrolysis ranging from 1.7-20.6 with 
antioxidant activity ranging from 28% to 65% [138]. Zhang and coworkers [139] used three 
microbial proteases to produce hydrolysates with degree of hydrolysis values from 13.4% to 
26.1% and with different oxygen radical absorbance capacity (ORAC), DPPH-radical 
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Source of 
proteins or 
hydrolysates 
In vitro methods 
used in measuring 
antioxidant 
capacity 
Enzymes or other 
process conditions 
used 
Antioxidative peptides 
identified 
Ref 
Potato liquid 
fraction 
ABTS+- scavenging Alcalase1, 
Esperase, Neutrase 
Not specified [13] 
Potato protein 
concentration 
ABTS+-- scavenging 
Emulsion oxidative 
stability 
Alcalase SSEFTY 
IYLGQ 
[14] 
Soybean proteins Liposome 
oxidizing system 
Chymotrypsin, 
Pepsin, Papain, 
Flavourzyme, 
Alcalase, Protamex 
Not specified [51]   
Soybean protein 
b-conglycin  
Linoleic acid 
peroxidation 
system 
Protease M, 
Protease N, 
Protease P, 
Protease S 
VNPHDHQN 
LVNPHDQN 
LLPHH 
LLPHHADADY 
VIPAGYP 
LQSGDALRVPSGTTYY 
[141] 
Yellow pea seed 
protein 
Radical (DPPH, O2-
, H2O2) scavenging 
and inhibition of 
linoleic acid 
oxidation 
Thermolysin NRYHE [135]  
Barley glutelin Radical scavenging 
capacity (DPPH/O2-
/OH-), Fe2+-
chelating effect and 
reducing power 
Alcalase QKPFPQQPPF 
PQIPEEF 
LRTLPMSVNVPL 
[54] 
Wheat gluten Linoleic acid 
peroxidation 
system 
Pepsin LQPGQGQQG 
AQIPQQ 
[56] 
Rice endosperm 
protein 
O2-, OH and DPPH 
radical 
sacavenging 
capacity, Linoleic 
acid peroxidation 
system 
Alcalase, 
Chymotrypsin, 
Neutrase, Papain, 
Flavorase 
FRDEHKK 
KHNRGDEF 
[151] 
1 The enzyme indicated in bold is the most effective of the enzymes to produce antioxidative activity/peptides 
Table 2. Antioxidative capacity of plant protein-derived hydrolysates and peptides 
scavenging activities as well transition metal chelating activities. Chen and coworkers [140] 
isolated 6 antioxidative peptide fragments from the digests of -conglycinin, a main soybean 
protein component, by using protease S from Bacillus sp. The antioxidant activity of the 
soybean hydrolysates, based on a linoleic acid oxidation system study, was attributed to the 
Leu-Leu-Pro-His-His peptide sequence [89, 93]. A potent antioxidant peptide, with 
inhibitory activity of lipid peroxidation, was isolated from soy protein isolate hydrolysed by 
 
Antihypertensive Properties of Plant Protein Derived Peptides 163 
Alcalase. Purification of peptide by ultrafiltration and chromatographic techniques 
enhanced the specific activity 67.9-fold compared to hydrolysate. The final potent 
antioxidant peptide contained hydrophobic amino acids and among them, Phe was 
especially abundant [141]. 
Pea and mung bean protein digests have been reported to possess antihypertensive activity 
in SHR [48, 142]. Mung bean protein hydrolysate prepared with alcalase decreased 
significantly SBP (-30.8 mmHg) of SHR 6 h after single oral administration at a dose of 600 
mg/ml. The blood pressure-lowering effect continued for at least 8 h, and the blood pressure 
returned to initial levels at 12 h after administration [48]. Single administration of mung 
bean raw sprout extract (at dose of 600 mg/kg) reduced significantly SBP (-40 mmHg) 6 h 
after administration. Plasma ACE activities in the treated rats also decreased (0.007 Unit/ml). 
Long-term intervention (1 month) test showed that blood pressure in the treated animals 
fluctuated according to the treatments. While raw sprout extract showed effective results 
after 1 week of intervention, dried sprout extracts did not have significant effects until 2 
weeks [142]. Pea protein hydrolysate was made by thermolysin action followed by 
membrane filtration. Oral administration of the pea protein hydrolysate, containing <3 kDa 
peptides, to SHR at doses of 100 and 200 mg/kg body weight led to a lowering of SBP, with a 
maximum reduction of 19 mmHg at 4 h. In contrast, orally administered unhydrolysed pea 
protein isolate had no blood pressure reducing effect in SHR, suggesting that thermolysin 
hydrolysis may have been responsible for releasing bioactive peptides from the native 
protein [143]. Pea protein peptides from in vitro gastrointestinal digestion were observed to 
absorb poorly with in vitro model and the hypotensive effect was tested with intravenous 
administration [144].   
2.4.4. Cereals 
The seed storage proteins of wheat, barley, rye, and oats contain known ACE-inhibitory di- 
and tripeptides in their primary structures. Barley and barley by-products extract possesses 
a biological activity such as free radical scavenging activity, tyrosinase, xanthin oxidase, and 
ACE-inhibition effect [145]. Hydrolysates of barley prolamin fraction exhibited the highest 
antioxidant and ACE-inhibitory activity compared to other protein fractions and protein 
isolate. Moreover, positive correlations were obtained between antioxidant and ACE-
inhibitory activity and the degree of hydrolysis of hydrolysed protein fractions and protein 
isolate [146]. 
The computer analysis of amino acid sequences of wheat gliadins made by means of 
BIOPEP database [147] showed the presence of fragments that are homological with the 
sequences regarded as antihypertensive peptides. They were: Leu-Gln-Pro (α-, β- and γ-
gliadins), Pro-Tyr-Pro (α-, β- and γ-gliadins), Ile-Pro-Pro (α-and β-gliadins), Leu-Pro-Pro (γ-
gliadins) and Leu-Val-Leu (γ-gliadins). Bioinformatic analysis of cereal proteins sequences 
revealed that particularly four tripeptides with known ACE-inhibitory activity, Leu-Gln-
Pro, Val-Pro-Pro, Ile-Pro-Pro, and Leu-Leu-Pro, are frequently encrypted in the primary 
structure of rye secalin, wheat gluten, and barley hordein. Sourdoughs fermented with 
different strains showed different concentrations of Leu-Gln-Pro and Leu-Leu-Pro. These 
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differences corresponded to strain-specific differences in endopeptidase (PepO) and 
aminopeptidase (PepN) activities. The highest levels of peptides Val-Pro-Pro, Ile-Pro-Pro, 
Leu-Gln-Pro, and Leu-Leu-Pro, 0.23, 0.71, 1.09, and 0.09 mmol/ kg dry matter (DM), 
respectively, were observed in rye malt: gluten sourdoughs fermented with Lactobacillus 
reuteri TMW 1.106 and added protease [148]. Several clinical trials with hypertensive 
humans show a moderate but relatively consistent reduction of blood pressure upon 
consumption of the fermented milk products containing Val-Pro-Pro and Ile-Pro-Pro [88, 
112]. Cheung and co-workers [149] used in silico approach to evaluate the potential of using 
oats as a protein source for generation of ACE-inhibitory peptides, and to screen for 
candidate enzymes to hydrolyse the oat protein for this purpose. It was found that 
thermolysin under high enzyme to substrate ratio (3%) and short time (20 min) conditions 
produced strong and stable ACE-inhibitory activity.  
Barley glutelin possess high hydrophobic amino acid content and enzymatic release by 
Alcalase produced peptides that had antioxidant capacity. Large size peptides possessed 
stronger DPPH scavenging activity and reducing power, whereas small-sized peptides were 
more effective in Fe2+ and hydroxyl radical scavenging activity [54]. Pepsin hydrolysis of by-
product of the wheat starch industry has shown antioxidant properties. Especially 
ultrafiltration produced fraction showed strong inhibition of the autoxidation of linoleic acid 
and scavenging activity of DPPH, superoxide and hydroxyl free radicals. The molecular 
weight distribution ranged from 0.1-1.7 kDa and high content of total hydrophobic amino 
acid was found in the active fraction [150]. Rice endosperm protein was, respectively, 
digested by five different protease treatments (Alcalase, chymotrypsin, Neutrase, Papain 
and Flavorase), and Neutrase produced the most desirable quality of antioxidant peptides. 
Two different peptides showing strong antioxidant activities were isolated from the 
hydrolysate using consecutive chromatographic methods. Especially, Phe-Arg-Asp-Glu-His-
Lys-Lys significantly inhibited lipid peroxidation in a linoleic acid emulsion system more 
effectively than α-tocopherol [151]. 
The Alcalase-generated rice hydrolysate showed ACE-inhibitory activity with an IC50 value of 
0.14 mg/ml. A potent ACE-inhibitory peptide with the amino acid sequence of Thr-Gln-Val-
Tyr (IC50 of 18.2 µM) was isolated and identified from the hydrolysate. Single oral 
administration of the hydrolysate (600 mg/kg) and Thr-Gln-Val-Tyr (30 mg/kg) showed 
significantly decreased blood pressure in SHR, -25.6 and -40 mmHg SBP, respectively, after 6h 
[152]. Three strong ACE-inhibitors with the Leu-Arg-Pro, Leu-Ser-Pro and Leu-Gln-Pro 
sequences were isolated from maize α-zein hydrolysed with thermolysin. After intravenous 
administration of these peptides (30 mg/kg body weight), SBP was found to decrease up to a 
maximum of 15 mmHg [31]. Moreover, a tripeptide (Ile-Val-Tyr) isolated from wheat germ 
hydrolysate reduced MAP of 19.2 mmHg at dose of 5 mg/ml in SHR [153]. 
3. Bioavailability 
Bioavailability is a major issue when establishing correspondence between in vitro and in 
vivo activities of bioactive peptides. The capacity to reach target organ in an active 
conformation determines the physiological effect of bioactive peptides. Various processes 
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take place after oral administration of a bioactive peptide and need to be considered on the 
final activity. It’s highly likely that antihypertensive reported peptide sequences are 
subjected to alteration before the final activity in vivo after the various steps, such as attack 
of gastrointestinal enzymes and brush border peptidases, absorption through the intestinal 
barrier, attack of intracellular peptidases in the transcellular absorption and plasma 
enzymes after the peptides have entered the circulation [58, 154]. Therefore, the different 
aspects of bioavailability of antihypertensive peptide sequences have attracted a growing 
interest in the last years. The possibility of modification or breakdown of peptides during 
the gastrointestinal digestion is one of the most important factors to be considered when 
evaluating potential food-derived peptides for promotion of human health. Various models 
have been implemented to simulate gastrointestinal digestion; static and dynamic models 
which both differ in enzymes applied and reaction conditions, such as agitation and 
duration. For instance, authors in references [155] and [47] utilized human digestive liquids 
to model digestion in vitro whereas several reports have concerned implementation of 
porcine enzyme mixtures [e.g. 60, 127, 132]. In addition to studying the resistance of 
antihypertensive peptide sequences against the digestive enzymes, the models have been 
utilized in order to produce bioactive peptides, plant derived ACE-inhibitory peptides 
among them. For instance pea, lentil, bean and chickpea proteins have been reported to 
release ACE-inhibitory peptides during in vitro digestion [40, 127, 132]. The digestive 
characteristics of commercial proteases mixtures are known to differ from those of human 
origin [155]. Zhu and co-workers [156] reported that the antioxidative activity of a zein 
hydrolysate, which had previously shown antioxidant activity in aqueous solutions and in 
food systems, was either decreased or improved during the course of in vitro digestion, 
depending on the enzymes encountered and the duration of hydrolysis. Thus, direct 
comparison of the results between the different models is difficult. A consensus concerning 
the basic parameters would be relevant in order to harmonize the various in vitro digestion 
models.  
Study of intestinal absorption in vitro is another common aim when elucidating the 
bioavailability. It has been indicated that a small portion of bioactive peptides can pass the 
intestine barrier and although it is usually too small to be considered nutritionally 
important, it can present the biological effects in tissue level [157, 158]. Molecular size and 
structural properties, such as hydrophobicity, affect the major transport route for peptides 
[158]. Research findings indicate that peptides with 2–6 amino acids are absorbed more 
readily in comparison to protein and free amino acids. As the molecular weight of peptides 
increases, their chance to pass the intestinal barrier decreases. Peptides are transported by 
active transcellular transport or by passive process [159]. The absorption studies are 
commonly performed with the monolayer of intestinal cell lines, such as Caco-2 cells, 
simulating intestinal epithelium, and analysis of peptides and metabolites in serum after in 
vivo and clinical studies. Foltz et al. [160] investigated the transport of Ile-Pro-Pro and Val-
Pro-Pro by using three different absorption models and demonstrated that these tri-peptides 
are transported in small amounts intact across the barrier of the intestinal epithelium. In 
another study, the absolute bioavailability of the tri-peptides in pigs was below 0.1%, with 
an extremely short elimination half-life ranging from 5 to 20 min [161]. In humans, maximal 
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plasma concentration did not exceed picomolar concentration [162]. Studies concerning 
absorption of plant derived peptides are rare, but milk-derived peptide Leu-His-Leu-Pro-
Leu-Pro is an interesting example of a peptide with evaluation of bioavailability. This 
peptide resisted gastrointestinal simulation, but cellular peptidases digested the peptide to 
His-Leu-Pro-Leu-Pro before crossing Caco-2 cell monolayer [163, 164]. The degradation 
product, His-Leu-Pro-Leu-Pro, has been demonstrated to absorb in human intestine as it has 
been identified in human plasma after oral administration [165]. 
Fujita and colleagues [166] established a bioavailability factor in relation to antihypertensive 
activity and ACE inhibition mechanism. The classification is based on inhibitor type and 
substrate type, the possible conversion of peptides by ACE into peptides with weaker 
activity and pro-drug type inhibitors, or possible conversion of peptides into true inhibitors 
by ACE or gastrointestinal proteases. A delayed antihypertensive effect is characteristic for 
pro-drug type peptides as they need to degrade further to reach the final active form [167, 
168]. For instance, flaxseed protein showed pro-drug type characteristics compared to 
hydrolysed cationic peptide fraction [126]. The protein fraction showed a delayed 
hypotensive effect in SHR comparable to captopril (3 mg/kg body weight) and the effect was 
more sustained than the effect of the digested peptide fraction. The slow-acting character of 
the protein fraction was expected since the digestion of the proteins. Anyhow, more 
research is needed to identify the active peptide sequences released in the digestive tract 
and to evaluate the bioavailability of these peptides. 
It can be deduced due to the incomplete bioavailability of peptide following oral ingestion, a 
peptide with pronounced antioxidant activity in vitro may exert little or no activity in vivo. 
However, bypass routes which increase the chance of peptide absorption can diminish the 
problem and it is possible that in vivo antioxidant activity can be higher than in vitro activity. 
In such cases, bioactive peptides may display their biological functions by mechanisms 
other than what is applied in experiment. In addition, it has been suggested that the strong 
in vivo activity can be due to increased activity of peptides following their breakdown by 
gastrointestinal proteases [88]. 
The improvement and optimization of bioavailability of antihypertensive peptides have 
gained a great interest during the last decade. The improvement of limited absorption and 
stability of peptides has been a goal when evaluating their effectiveness. For example, some 
carriers interact with the peptide molecule to create an insoluble entity at low pH, which 
later dissolves and facilitates intestinal uptake, by enhancing peptide transport over the 
non-polar biological membrane [169]. Bioavailability of bioactive tri-peptides (Val-Pro-Pro, 
Ile-Pro-Pro, Leu-Pro-Pro) was improved by administering them with a meal containing 
fibre, as compared to a meal containing no fibre. High methylated citrus pectin was used as 
a fibre [170]. Among drug delivery systems, emulsions have been used to enhance oral 
bioavailability or promoting absorption through mucosal surfaces of peptides and proteins 
[169]. Individually, various components of emulsions have been considered as candidates 
for improving bioavailability of peptides. Anyhow, it seems that no general strategy for 
improving bioavailability of antihypertensive peptides exists and due to the number of 
processes involved and different characteristics of peptides depending on the sequence each 
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case must be studied. Many strategies are currently demonstrated for enhancing 
bioavailability [171], among them microencapsulation for controlled release of the active 
compounds, stabilization of the active molecules to improve transportation through the 
intestinal barrier and provide resistance against degradation, and development of highly 
stabile peptide analogues [172-174]. 
4. Health benefits 
ACE-inhibitory peptides have been studied extensively in the past two decades and ACE-
inhibition is the main mechanism concerning bioactive peptides with proven 
antihypertensive effects. ACE is a constituent enzyme of the Renin-Angiotensin-Aldosterone 
System (RAAS), which is a crucial regulator in human physiology. It controls blood 
pressure, fluid and electrolyte balance and affects the heart, vasculature and kidney [2]. 
Among the food-derived ACE-inhibitory peptides milk-derived peptides are the most 
extensively studied. The relevance of vegetable proteins as a source of antihypertensive 
peptides is increasing and several in vivo studies performed in SHR have demonstrated that 
plant-derived ACE-inhibitory protein hydrolysates and peptides significantly reduce blood 
pressure, either after oral or intravenous administration. For instance, a clinical randomized, 
placebo-controlled crossover study was performed in order to elucidate further the 
antihypertensive potential of yam tuber dioscorins [175]. The dioscorin meal or placebo was 
intervened as a morning drink daily for five weeks, followed by a washout stage for one 
week and the trial was then crossed over for five weeks. The SBP and DBP values were 
decreased after the five weeks of dioscorin meal intervention. The clinical trial as well as the 
animal trials with dioscorin intervention suggests that the gastrointestinal digestion may 
produce antihypertensive peptides from the yam tuber dioscorins. 
Furthermore, related to the RAAS, plant derived ACE-inhibitory peptides have been 
reported to possess inhibition activity against renin, the first and rate-determining enzyme 
in RAAS [2]. The inhibition of renin is being suggested as a major alternative in 
hypertension prevention. The first direct renin-inhibitor, aliskiren, is currently under phase 
III trials to evaluate its potential as an antihypertensive drug [176]. Thermolysin digest of 
pea protein decreased remarkably the renal expression of renin mRNA levels in vivo and 
lowered plasma levels of angiotensin II, thus the reduction in blood pressure in SHR and 
human subjects was likely due to the effects on the renal angiotensin system [143]. Pea-
derived peptides Ile-Arg, Lys-Phe and Glu-Phe showed strong inhibitions in vitro studies of 
ACE and renin [133] as well as ACE-inhibitory peptide fractions from flaxseed protein 
hydrolysates possessed inhibition also against renin [126, 177, 178].  
Opioid receptors are involved in various physiological phenomenons, e.g. in the regulation 
of blood pressure and circulation, and these receptors are related to the antihypertensive 
properties of some food derived peptides. Other vasodilatory substances, such as ET-1, have 
also been suggested to be involved in the antihypertensive effects of food-derived peptides 
[173, 178, 179]. However, peptide sequences derived specifically from plant proteins 
inducing endothelial NO liberation have not been reported this far. A cationic Arg-rich 
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peptide fraction from flaxseed, which possessed hypotensive effects in SHR, was suggested 
to mediate blood pressure through vasodilatory activity of NO synthesized from Arg. The 
observed effect might also be due to ACE- and renin-inhibition and in-depth research is 
needed to measure the renin and ACE protein levels and activities in SHR tissues and 
plasma and to specify the prior mechanism of antihypertensive action [44]. 
Calmodulin (CaM) –dependent cyclic nucleotide phosphodiesterase (CaMPDE) regulates a 
large variety of cellular functions and excessive levels of CaM and CaMPDE play important 
roles in many physiological conditions, symptoms of cardiovascular disease among them. 
Recently, food derived peptides capable to inhibit CaMPDE have been reported, flaxseed 
and pea protein derived peptides among them [125, 133, 178]. Oxidative stress is a crucial 
causative factor for the initiation and progression of hypertension and CVD. Increased 
production of ROS, such as H2O2 and superoxide anion, reduced NO synthesis, and 
decreased bioavailability of antioxidants have been demonstrated in experimental and 
human hypertension. Diet rich in antioxidants can reduce blood pressure and thus, 
antioxidant properties of food-derived peptides may also affect on blood pressure 
regulation [180, 181]. Several food derived peptides have been reported to possess dual 
(ACE-inhibition and antioxidant) activity, among them plant protein derived hydrolysates 
of flaxseed [44, 55,182], rapeseed [47], potato [13] and yam [115, 116]. 
New mechanisms of action of antihypertensive peptides have been demonstrated in the 
recent years. The antihypertensive effect of a rapeseed derived tri-peptide rapakinin, was 
suggested to be mediated through other mechanism than ACE-inhibition [125]. Later on, 
different mechanisms were considered and the vasorelaxing activity of rapakinin was not 
blocked by eNOS inhibitor, while antagonists of IP and CCK1 receptor blocked the 
vasorelaxing effect of rapakinin significantly [128]. The results demonstrated that rapakinin 
relaxes the mesenteric artery of SHR through the PGI2-IP receptor followed by CCK 
pathway and the antihypertensive activity is mediated mainly by the PGI2-IP CCK-CCK1 
receptor-dependent vasorelaxation. Moreover, inhibition of platelet-activating factor 
acetylhydrolase (PAF-AH) is suggested to play a crucial role in the hypertension prevention. 
PAF-AH is a circulatory enzyme secreted by inflammatory cells and it is involved in 
atherosclerosis. The discovery and application of natural PAF-AH into health promoting 
foods open up considerable potential [183].  
5. General conclusions 
The interest on foods possessing health-promoting or disease-preventing properties has 
been increasing. So far most of the studies on antihypertensive peptides have been done on 
milk protein-derived peptides. In fact, much work has been done with dietary 
antihypertensive peptides and evidence of their effect in animal and clinical studies. 
However, it has been highlighted that there is a huge potential for obtaining 
antihypertensive peptides from protein sources other than milk. Much work has been done 
on plant protein hydrolysates and their activity in vitro. So far only limited number of 
peptides has been identified from plant proteins. In addition very little is known on the 
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activity of these hydrolysates and peptides in animal or in humans. These findings open up 
an interesting field aiming to revaluation of plant derived protein-rich by-products formed 
in food industry processes in remarkable amounts.  
Certain aspects, such as identification of the active form of the peptides in the organism and 
the different mechanisms of action that contribute in the antihypertensive effect still need to 
be further investigated. Recent advances on specific analytical techniques enable to follow 
small amounts of the peptides or derivatives in complex matrices and biological fluids. This 
will allow performing the kinetic studies in model animals and humans. Similarly, 
identifying novel and more complex biomarkers of exposure and activity by advances in 
new disciplines such as nutrigenomic and nutrigenetic will open new ways to follow 
bioactivity in the organism. There is still poor knowledge on the resistance of peptides to 
gastric degradation, and low bioavailability of peptides has been observed. This reinforces 
the need of various strategies to improve the oral bioavailability of peptides. 
More emphasis has been put on the legal regulation of the health claims attached to the 
products. Systematic approaches for review and assessment of scientific data have been 
developed by authorities around the world. The scientific evidence on the beneficial effects 
of the product should be enough detailed, extensive and conclusive for the use of a health 
claim in the functional food product labeling and marketing. First, it is necessary to identify 
and quantify the active sequences in the product. It is mandatory to monitor the hydrolytic 
or fermentative industrial production process as the antihypertensive peptides are only 
minor constituents in highly complex food matrices. Second, the antihypertensive effect in 
humans as well as the minimal dose needed to show the effect has to be proven in extensive 
investigations to fulfill the requirements of the legislation concerning functional foods. 
Besides being based on generally accepted scientific evidence, the claims should be well 
understood by the average consumer. Japan is the pioneer in the area of regulation of the 
health claims concerning food products. The concept of Foods for Specified Health Use 
(FOSHU) was established in 1991. In EU, the European Regulation on nutrition and health 
claims was established in January 2007 and the regulations are governed by European Food 
Safety Authority (EFSA). 
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